Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Sabbatini

Showing results (21-30 of 44) with videos related to

Pageof 5
Sort By:
Gynecologic Oncology|September 5, 2001
Endometrial stromal sarcoma: objective response to letrozoleF C Maluf, P Sabbatini, L Schwartz, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 15, 1992
The adenovirus E1A proteins induce apoptosis, which is inhibited by the E1B 19-kDa and Bcl-2 proteinsL Rao, M Debbas, P Sabbatini, et al.
Cell Growth & Differentiation : the Molecular Biology Journal of the American Association for Cancer Research|June 1, 1997
Interleukin 1 beta converting enzyme-like proteases are essential for p53-mediated transcriptionally dependent apoptosisP Sabbatini, J Han, S K Chiou, et al.
Genes & Development|February 15, 1996
The E1B 19K protein blocks apoptosis by interacting with and inhibiting the p53-inducible and death-promoting Bax proteinJ Han, P Sabbatini, D Perez, et al.
Biochimica Et Biophysica Acta|November 13, 1987
Identification of nuclear envelope proteins and glycoproteins which co-isolate with the nuclear protein matrixP J Smith, G P Sabbatini, K I Grant, et al.
Gynecologic Oncology|September 28, 2000
Intraperitoneal cisplatin and intravenous paclitaxel in the treatment of epithelial ovarian cancer patients with a positive second lookS Makhija, P Sabbatini, C Aghajanian, et al.
Water Research|July 6, 2010
Fabrication and characterization of iron oxide ceramic membranes for arsenic removalP Sabbatini, F Yrazu, F Rossi, et al.
Molecular and Cellular Biology|June 1, 1992
The 19-kilodalton adenovirus E1B transforming protein inhibits programmed cell death and prevents cytolysis by tumor necrosis factor alphaE White, P Sabbatini, M Debbas, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 2, 2005
Phase I trial of bortezomib and carboplatin in recurrent ovarian or primary peritoneal cancerC Aghajanian, D S Dizon, P Sabbatini, et al.
Gynecologic Oncology|August 25, 2001
The costs and efficacy of liposomal doxorubicin in platinum-refractory ovarian cancer in heavily pretreated patientsM L Hensley, B Hoppe, L Leon, et al.
Pageof 5

Showing results (21-30 of 44) with videos related to

Sort By:
Pageof 5
Gynecologic Oncology|September 5, 2001
Endometrial stromal sarcoma: objective response to letrozoleF C Maluf, P Sabbatini, L Schwartz, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 15, 1992
The adenovirus E1A proteins induce apoptosis, which is inhibited by the E1B 19-kDa and Bcl-2 proteinsL Rao, M Debbas, P Sabbatini, et al.
Cell Growth & Differentiation : the Molecular Biology Journal of the American Association for Cancer Research|June 1, 1997
Interleukin 1 beta converting enzyme-like proteases are essential for p53-mediated transcriptionally dependent apoptosisP Sabbatini, J Han, S K Chiou, et al.
Genes & Development|February 15, 1996
The E1B 19K protein blocks apoptosis by interacting with and inhibiting the p53-inducible and death-promoting Bax proteinJ Han, P Sabbatini, D Perez, et al.
Biochimica Et Biophysica Acta|November 13, 1987
Identification of nuclear envelope proteins and glycoproteins which co-isolate with the nuclear protein matrixP J Smith, G P Sabbatini, K I Grant, et al.
Gynecologic Oncology|September 28, 2000
Intraperitoneal cisplatin and intravenous paclitaxel in the treatment of epithelial ovarian cancer patients with a positive second lookS Makhija, P Sabbatini, C Aghajanian, et al.
Water Research|July 6, 2010
Fabrication and characterization of iron oxide ceramic membranes for arsenic removalP Sabbatini, F Yrazu, F Rossi, et al.
Molecular and Cellular Biology|June 1, 1992
The 19-kilodalton adenovirus E1B transforming protein inhibits programmed cell death and prevents cytolysis by tumor necrosis factor alphaE White, P Sabbatini, M Debbas, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 2, 2005
Phase I trial of bortezomib and carboplatin in recurrent ovarian or primary peritoneal cancerC Aghajanian, D S Dizon, P Sabbatini, et al.
Gynecologic Oncology|August 25, 2001
The costs and efficacy of liposomal doxorubicin in platinum-refractory ovarian cancer in heavily pretreated patientsM L Hensley, B Hoppe, L Leon, et al.
Pageof 5